EUCTR2006-001796-37-IT进行中（未招募）不适用
Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis - ALENDRONATE
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点目标入组 30 人开始时间: 2006年5月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •a. T-score -2.5 S.D. accrodng to WHO criteria with or without fractures; b. women in menopause since 1 year
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •a.legal or mental incapacity to give the informed consent; b. secondary osteoporosis; c. patients taking drugs active on bone metabolism d. patients taking immunosuppresant within the previous year e. previous adverse events with alendronate or calcium and vitamin D f. surgicall menopause g. history of cancer
研究者
相似试验
已完成
4 期
Effects of long-acting alendronate on osteoporosis with impaired glucose metabolismOsteoporosisJPRN-UMIN000000987ational Hospital Organization, Kyoto Medical Center100
已完成
3 期
Effect of Alendronate in Patents with Osteoporosis and Chronic Kidney DiseaseChronic Kidney Disease Stage 3a-3b.Chronic kidney disease, stage 3 (moderate)IRCT20180506039549N1Ahvaz University of Medical Sciences82
已完成
不适用
The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplastyPost hip arthroplastyJPRN-UMIN000004847Juntendo University Nerima Hospital36
已完成
不适用
Efficacy of Alendronate for the Prevention of Bone Loss in Calcar Region Following Total Hip Arthroplasty.Osteoarthritis of hip jointJPRN-UMIN000027501Yokohama City University90
已完成
2 期
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile OsteoporosisOsteoporosisNCT00010439Medical University of South Carolina10